M1095
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for M1095, covering 2021-08-02 to 2021-08-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis [Phase 2]